Bruce Power's Chief Operating Officer James Scongack is Chairman of the Canadian Nuclear Isotope Council and, as he explains, the country aims to play a leadership role in nuclear medicine, not just for Canada's benefit, but also to provide health benefits for the rest of the world.
He outlines the life-saving diagnostics and treatments that now exist thanks to isotopes produced in Canada's Candu reactors, research reactors and cyclotrons, and talks about the new trials and treatments which are emerging.
The Canadian Nuclear Isotope Council has recently signed an agreement with the International Atomic Energy Agency's Rays for Hope campaign and aims to help provide access to nuclear medicine's diagnostics and treatments to those parts of the world where people do not currently have access. This is part of what he sees as driving hugely growing demand in the years ahead.
For those who may say that producing isotopes is the equivalent of a 'side hustle' for a nuclear power plant, Scongack says it might be "1% of the cashflow, but it's 50% of our contribution" in terms of tackling some of the greatest challenges that communities and society are facing.
Scongack also talks about progress at Bruce Power, where the modernisation programme is adding extra capacity equivalent to that which would be provided by building three small modular reactors. There's also an update on Bruce C.
Scongack, who sees a bright future for nuclear energy in general, says that communicating positive stories is key. He presents the Canadian Nuclear Isotopes Council's own podcast - called Isotopes for Hope- helping to spread the news about what he calls a "real hidden gem of what our industry around the world does".
Podden och tillhörande omslagsbild på den här sidan tillhör
World Nuclear News. Innehållet i podden är skapat av World Nuclear News och inte av,
eller tillsammans med, Poddtoppen.